Prior to founding CHARM, he was a core contributor at Exscientia (NASDAQ:EXAI), a leading AI drug discovery company, where he worked on their machine learning platform.
Prior to founding CHARM, he was a core contributor at Exscientia (NASDAQ:EXAI), a leading AI drug discovery company, where he worked on their machine learning platform.